EPISODE · May 29, 2025 · 19 MIN
BioAge is translating insights from the science of aging into new medicines
Scott Neidhold, Director in RBC’s Life Sciences Investment Banking Practice, sits down with Kristen Fortney, CEO and Co-Founder of BioAge, for a deep dive into how her company is turning cutting-edge aging science into real therapeutic breakthroughs — and what it means for the future of biopharma.
Embed this episode
NOW PLAYING
BioAge is translating insights from the science of aging into new medicines
0:00
19:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 19 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on May 29, 2025.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!